Clinical Trial Update: Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies

View source ↗

Summary

This clinical trial update discusses the duration of effect of alipogene tiparvovec (Glybera) when given in previous studies for Hyperlipoproteinemia Type I; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia Type

Drugs mentioned

• Glybera (alipogene tiparvovec)

Snippet

Sponsor: Amsterdam Molecular Therapeutics | Conditions: Hyperlipoproteinemia Type I | Status: TERMINATED